Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-16

Clinical Trial Update: Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Kalinox 170 Bar for cancer-related pain in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kalinox 170 Bar (nitrous oxide)

Snippet

Sponsor: Air Liquide Santé International | Conditions: Cancer, Pain | Phase 4 | Status: COMPLETED